Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Harvard Bioscience (HBIO) Return on Equity (2016 - 2025)

Historic Return on Equity for Harvard Bioscience (HBIO) over the last 15 years, with Q3 2025 value amounting to 3.61%.

  • Harvard Bioscience's Return on Equity fell 33900.0% to 3.61% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.61%, marking a year-over-year decrease of 33900.0%. This contributed to the annual value of 0.18% for FY2024, which is 1300.0% down from last year.
  • As of Q3 2025, Harvard Bioscience's Return on Equity stood at 3.61%, which was down 33900.0% from 3.75% recorded in Q2 2025.
  • Harvard Bioscience's 5-year Return on Equity high stood at 0.01% for Q4 2021, and its period low was 3.75% during Q2 2025.
  • Over the past 5 years, Harvard Bioscience's median Return on Equity value was 0.09% (recorded in 2022), while the average stood at 0.54%.
  • Its Return on Equity has fluctuated over the past 5 years, first skyrocketed by 900bps in 2021, then tumbled by -35900bps in 2025.
  • Quarter analysis of 5 years shows Harvard Bioscience's Return on Equity stood at 0.01% in 2021, then tumbled by -1589bps to 0.14% in 2022, then soared by 66bps to 0.05% in 2023, then crashed by -309bps to 0.19% in 2024, then crashed by -1783bps to 3.61% in 2025.
  • Its Return on Equity was 3.61% in Q3 2025, compared to 3.75% in Q2 2025 and 1.48% in Q1 2025.